1887
Euroroundup Open Access
Like 0

Abstract

As the COVID-19 pandemic began in early 2020, primary care influenza sentinel surveillance networks within the Influenza - Monitoring Vaccine Effectiveness in Europe (I-MOVE) consortium rapidly adapted to COVID-19 surveillance. This study maps system adaptations and lessons learned about aligning influenza and COVID-19 surveillance following ECDC / WHO/Europe recommendations and preparing for other diseases possibly emerging in the future. Using a qualitative approach, we describe the adaptations of seven sentinel sites in five European Union countries and the United Kingdom during the first pandemic phase (March–September 2020). Adaptations to sentinel systems were substantial (2/7 sites), moderate (2/7) or minor (3/7 sites). Most adaptations encompassed patient referral and sample collection pathways, laboratory testing and data collection. Strengths included established networks of primary care providers, highly qualified testing laboratories and stakeholder commitments. One challenge was the decreasing number of samples due to altered patient pathways. Lessons learned included flexibility establishing new routines and new laboratory testing. To enable simultaneous sentinel surveillance of influenza and COVID-19, experiences of the sentinel sites and testing infrastructure should be considered. The contradicting aims of rapid case finding and contact tracing, which are needed for control during a pandemic and regular surveillance, should be carefully balanced.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2022.27.26.2100864
2022-06-30
2022-08-10
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2022.27.26.2100864
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/27/26/eurosurv-27-26-3.html?itemId=/content/10.2807/1560-7917.ES.2022.27.26.2100864&mimeType=html&fmt=ahah

References

  1. Phillips N. The coronavirus is here to stay - here’s what that means. Nature. 2021;590(7846):382-4.  https://doi.org/10.1038/d41586-021-00396-2  PMID: 33594289 
  2. Bernal JL, Sinnathamby MA, Elgohari S, Zhao H, Obi C, Coughlan L, et al. The impact of social and physical distancing measures on COVID-19 activity in England: findings from a multi-tiered surveillance system. Euro Surveill. 2021;26(11):2001062.  https://doi.org/10.2807/1560-7917.ES.2021.26.11.2001062  PMID: 33739255 
  3. Égart B, Guillemette Y, Murtin F, Turner D. Walking the tightrope: Avoiding a lockdown while containing the virus. OECD Economics Department Working Papers, No. 1633. Paris: OECD Publishing. 2020.  https://doi.org/10.1787/18151973 
  4. European Centre for Disease Prevention and Control (ECDC). Strategies for the Surveillance of COVID-19. Technical report. Stockholm: ECDC; 9 Apr 2020. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-surveillance-strategy-9-Apr-2020.pdf
  5. World Health Organization (WHO). Operational considerations for COVID-19 surveillance using GISRS: interim guidance. Geneva: WHO; 26 Mar 2020. Available from: https://www.who.int/publications/i/item/operational-considerations-for-covid-19-surveillance-using-gisrs-interim-guidance
  6. World Health Organization Regional Office for Europe (WHO/Europe). Strengthening the health system response to COVID-19 in the WHO transmission scenarios. Action points for the WHO European Region. Copenhagen: WHO/Europe; 1 Apr 2020. Available from: https://apps.who.int/iris/handle/10665/333075
  7. European Centre for Disease Prevention and Control (ECDC); World Health Organization Regional Office for Europe. (WHO/Europe). Flu news Europe. [Accessed: 2 Oct 2020]. Available from: https://flunewseurope.org
  8. Valenciano M, Ciancio B. on behalf of the I-MOVE study team C; I-MOVE study team. I-MOVE: a European network to measure the effectiveness of influenza vaccines. Euro Surveill. 2012;17(39):20281.  https://doi.org/10.2807/ese.17.39.20281-en  PMID: 23041022 
  9. I-MOVE-COVID-19 network. COVID-19 European Primary Care surveillance: Generic Protocol. 2020. Available from: https://www.imoveflu.org/i-move-covid-19/i-move-covid-19-publications/
  10. Mahase E. Covid-19: What new variants are emerging and how are they being investigated? BMJ. 2021;372(158):n158.  https://doi.org/10.1136/bmj.n158  PMID: 33462092 
  11. World Health Organization (WHO). Surveillance strategies for COVID-19 human infection. Geneva: WHO; 10 May 2020. Available from: https://apps.who.int/iris/bitstream/handle/10665/332051/WHO-2019-nCoV-National_Surveillance-2020.1-eng.pdf?sequence=1&isAllowed=y
  12. de Lusignan S, Lopez Bernal J, Zambon M, Akinyemi O, Amirthalingam G, Andrews N, et al. Emergence of a Novel Coronavirus (COVID-19): Protocol for Extending Surveillance Used by the Royal College of General Practitioners Research and Surveillance Centre and Public Health England. JMIR Public Health Surveill. 2020;6(2):e18606.  https://doi.org/10.2196/18606  PMID: 32240095 
  13. de Lusignan S, Jones N, Dorward J, Byford R, Liyanage H, Briggs J, et al. The Oxford royal college of general practitioners clinical informatics digital hub: protocol to develop extended COVID-19 Surveillance and Trial Platforms. JMIR Public Health Surveill. 2020;6(3):e19773.  https://doi.org/10.2196/19773  PMID: 32484782 
  14. World Health Organization (WHO). Global epidemiological surveillance standards for influenza. Geneva: WHO; 9 Aug 2013. Available from: https://www.who.int/publications/i/item/9789241506601
  15. World Health Organization (WHO). Sentinel sites and specimens. ILI and SARI case definition. Geneva: WHO. [Accessed: 12 Jul 2021]. Available from: https://www.who.int/teams/global-influenza-programme/influenza-covid19/sentinel-sites-and-specimens
  16. Butler CC, Dorward J, Yu L-M, Gbinigie O, Hayward G, Saville BR, et al. Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Lancet. 2021;397(10279):1063-74.  https://doi.org/10.1016/S0140-6736(21)00461-X  PMID: 33676597 
  17. de Lusignan S, Borrow R, Tripathy M, Linley E, Zambon M, Hoschler K, et al. Serological surveillance of influenza in an English sentinel network: pilot study protocol. BMJ Open. 2019;9(3):e024285.  https://doi.org/10.1136/bmjopen-2018-024285  PMID: 30852535 
  18. World Health Organization (WHO). WHO COVID-19 Case definition. Geneva: WHO; 16 Dec 2020. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-Surveillance_Case_Definition-2020.2
  19. Tsopra R, Frappe P, Streit S, Neves AL, Honkoop PJ, Espinosa-Gonzalez AB, et al. Reorganisation of GP surgeries during the COVID-19 outbreak: analysis of guidelines from 15 countries. BMC Fam Pract. 2021;22(1):96.  https://doi.org/10.1186/s12875-021-01413-z  PMID: 34000985 
  20. Melidou A, Pereyaslov D, Hungnes O, Prosenc K, Alm E, Adlhoch C, et al. Virological surveillance of influenza viruses in the WHO European Region in 2019/20 - impact of the COVID-19 pandemic. Euro Surveill. 2020;25(46):2001822.  https://doi.org/10.2807/1560-7917.ES.2020.25.46.2001822  PMID: 33213683 
  21. World Health Organization (WHO). Maintaining surveillance of influenza and monitoring SARS-CoV-2: adapting Global Influenza Surveillance and Response System (GISRS) and sentinel systems during the COVID-19 pandemic: interim guidance. Geneva: WHO; 2020. Available from: https://www.who.int/publications/i/item/maintaining-surveillance-of-influenza-and-monitoring-sars-cov-2-adapting-global-influenza-surveillance-and-response-system-(gisrs)-and-sentinel-systems-during-the-covid-19-pandemic
  22. Marbus SD, van der Hoek W, van Dissel JT, van Gageldonk-Lafeber AB. Experience of establishing severe acute respiratory surveillance in the Netherlands: Evaluation and challenges. Public Health Pract (Oxf). 2020;1:100014.  PMID: 34171043 
/content/10.2807/1560-7917.ES.2022.27.26.2100864
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error